Evidence map›Paper›PMID 31303399›Full record

ArticleImmunity2019

The Cytokine TNF Promotes Transcription Factor SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair.

Anthony Kusnadi, Sung Ho Park, Ruoxi Yuan, Tania Pannellini, Eugenia Giannopoulou, David Oliver, Theresa Lu, Kyung-Hyun Park-Min, Lionel B Ivashkiv

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Regulation of macrophage transcriptional dynamics during acute and chronic wound repair.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Anthony KusnadiImmunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA; Research Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA.
Sung Ho ParkResearch Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA; School of Life Sciences, Ulsan National Institute of Science & Technology (UNIST), Ulsan 44919, Korea.
Ruoxi YuanResearch Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA.
Tania PannelliniResearch Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA.
Eugenia GiannopoulouResearch Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA; Biological Sciences Department, New York City College of Technology, City University of New York, Brooklyn, NY 11201, USA.
David OliverResearch Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA.
Theresa LuImmunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA; Research Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA.
Kyung-Hyun Park-MinBCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA; Research Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA. Electronic address: parkmink@hss.edu.
Lionel B IvashkivImmunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA; Research Institute and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA. Electronic address: ivashkivl@hss.edu.
Hospital for Special Surgery · USCornell University · USNew York City College of Technology · US

Funding

STEROID THERAPY AND CYTOKINES IN RHEUMATIC DISEASESR01AI046712 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 2000 to 2025
$12.5M
Inhibition of STAT3 and inflammatory cytokine productionR01AI044938 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 2000 to 2025
$9.2M
CYTOKINE REGULATION OF RA SYNOVIOCYTE PHENOTYPER01AR046713 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI IVASHKIV, LIONEL B · 1999 to 2025
$8.3M
Fc Receptors &Cytokine Balance in Rheumatoid ArthritisR01AR050401 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI Lionel B Ivashkiv · 2004 to 2026
$7.4M
Vascular-stromal function and regulation in immunityR01AI079178 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI Theresa T. Lu · 2010 to 2026
$6.6M
The Crosstalk between MYC and Metabolism during OsteoclastogenesisR01AR069562 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI PARK-MIN, KYUNG-HYUN · 2016 to 2020
$1.9M
A novel regulating pathway in osteoclastogenesis and arthritic bone resorptionR01AR073156 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI PARK-MIN, KYUNG-HYUN · 2018 to 2022
$1.9M
Negative Regulation of Osteoclastogenesis by Inflammatory SignalsR00AR061430 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI PARK-MIN, KYUNG-HYUN · 2014 to 2016
$747k
Cell SorterS10OD019986 · OD · HOSPITAL FOR SPECIAL SURGERY · PI LU, THERESA T. · 2015 to 2015
$600k
NIAID NIH HHS R01 AI044938NIAID NIH HHS R01 AI046712NIAID NIH HHS R01 AI079178NIAMS NIH HHS R00 AR061430NIAMS NIH HHS R01 AR046713NIAMS NIH HHS R01 AR050401NIAMS NIH HHS R01 AR069562NIAMS NIH HHS R01 AR073156NIH HHS S10 OD019986
6 · The paper itself

Abstract

Cytokine tumor necrosis factor (TNF)-mediated macrophage polarization is important for inflammatory disease pathogenesis, but the mechanisms regulating polarization are not clear. We performed transcriptomic and epigenomic analysis of the TNF response in primary human macrophages and revealed late-phase activation of SREBP2, the master regulator of cholesterol biosynthesis genes. TNF stimulation extended the genomic profile of SREBP2 occupancy to include binding to and activation of inflammatory and interferon response genes independently of its functions in sterol metabolism. Genetic ablation of SREBP function shifted the balance of macrophage polarization from an inflammatory to a reparative phenotype in peritonitis and skin wound healing models. Genetic ablation of SREBP activity in myeloid cells or topical pharmacological inhibition of SREBP improved skin wound healing under homeostatic and chronic inflammatory conditions. Our results identify a function and mechanism of action for SREBPs in augmenting TNF-induced macrophage activation and inflammation and open therapeutic avenues for promoting wound repair.

Indexed as

AnimalsCell DifferentiationCells, CulturedDisease Models, AnimalEpigenomicsFemaleHumansInflammationMacrophage ActivationMacrophagesMiceMice, Inbred C57BLMice, KnockoutPeritonitisPhenotypeReceptors, G-Protein-CoupledReceptors, G-Protein-CoupledRNA, Small InterferingSREB2 protein, mouseTumor Necrosis Factor-alphacholesterolepigenomicsinflammationmacrophage polarizationmacrophagesSREBP2tissue repairTNFtranscriptomicswound healing

Identifiers

PMID31303399
PMCPMC6709581
OpenAlexW2962552845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.